About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Rheumatology
›
top-articles
Division of Rheumatology
73
(top 1%)
papers
2.0K
(top 1%)
citations
22
(top 1%)
h
-index
44
(top 1%)
g
-index
81
all documents
2.2K
doc citations
630
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
Journal of Scleroderma and Related Disorders
2017
321
2
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
Autoimmunity Reviews
2020
231
3
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
Annals of the Rheumatic Diseases
2017
132
4
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Arthritis Research and Therapy
2012
110
5
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis
Nature Medicine
2017
99
6
Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management
Current Rheumatology Reports
2012
96
7
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis
Clinical Rheumatology
2007
84
8
Systemic Sclerosis
Rheumatic Disease Clinics of North America
2015
78
9
Corticosteroids and the risk of scleroderma renal crisis: a systematic review
Rheumatology International
2012
76
10
Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
Nature Communications
2019
76
11
Antinuclear antibody-negative systemic sclerosis
Seminars in Arthritis and Rheumatism
2015
60
12
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
European Respiratory Review
2018
53
13
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria
Journal of Clinical Epidemiology
2014
52
14
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis
Clinical Rheumatology
2014
48
15
Effect of menopause on the modified Rodnan skin score in systemic sclerosis
Arthritis Research and Therapy
2014
38
16
Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study
Rheumatology
2019
38
17
Anti-centromere antibodies in a large cohort of systemic sclerosis patients: Comparison between immunofluorescence, CENP-A and CENP-B ELISA
Clinica Chimica Acta
2011
35
18
Defining primary systemic sclerosis heart involvement: A scoping literature review
Seminars in Arthritis and Rheumatism
2019
35
19
Surveillance of systemic autoimmune rheumatic diseases using administrative data
Rheumatology International
2011
33
20
FRI0258 CUMULATIVE INCIDENCE, SURVIVAL AND PREDICTORS OF PULMONARY HYPERTENSION IN SYSTEMIC SCLEROSIS SUBSETS: PAH IS NOT INCREASED IN LIMITED VS DIFFUSE PATIENTS BY ADJUSTED COMPETING RISK ANALYSIS
Annals of the Rheumatic Diseases
2020
33
21
There is a need for new systemic sclerosis subset criteria. A content analytic approach
Scandinavian Journal of Rheumatology
2018
28
22
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis
Seminars in Arthritis and Rheumatism
2020
26
23
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets
Autoimmunity Reviews
2020
25
24
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies
RMD Open
2020
23
25
Longitudinal Study of Renal Function in Systemic Sclerosis
Journal of Rheumatology
2012
20
26
Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype
Autoimmunity Reviews
2018
19
27
Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients
Rheumatology
2022
19
28
Toward Understanding of Environmental Risk Factors in Systemic Sclerosis
Journal of Cutaneous Medicine and Surgery
2021
17
29
Histopathological features of systemic sclerosis-associated myopathy: A scoping review
Autoimmunity Reviews
2021
17
30
Autoantibody profiles delineate distinct subsets of scleromyositis
Rheumatology
2022
16
31
Embolic complications of a mitral valve rheumatoid nodule
Journal of Rheumatology
2004
16
32
Comparative effectiveness research with administrative health data in rheumatoid arthritis
Nature Reviews Rheumatology
2016
15
33
Systemic Sclerosis in Canada’s North American Native Population: Assessment of Clinical and Serological Manifestations
Journal of Rheumatology
2013
14
34
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues
Rheumatology
2016
13
35
An interim report of the Scleroderma Clinical Trials Consortium working groups
Journal of Scleroderma and Related Disorders
2019
13
36
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Rheumatology
2020
12
37
Subsets in systemic sclerosis: one size does not fit all
Journal of Scleroderma and Related Disorders
2016
11
38
Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort
Rheumatology
2017
11
39
Association between autoantibodies in systemic sclerosis and cancer in a national registry
Rheumatology
2022
11
40
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Clinical and Experimental Rheumatology
2021
11
41
The challenges and controversies of measuring disease activity in systemic sclerosis
Journal of Scleroderma and Related Disorders
2018
10
42
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis
Seminars in Arthritis and Rheumatism
2022
10
43
Exposure to silica and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group
Frontiers in Medicine
0
9
44
Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study
Rheumatology
2021
8
45
Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature
Clinical and Experimental Rheumatology
2015
8
46
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis
Neuropathology and Applied Neurobiology
2022
8
47
Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis
Clinical Rheumatology
2013
7
48
Erdheim-Chester Disease: The Importance of Information Integration
Case Reports in Oncology
2017
7
49
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’
Acta Neuropathologica
2021
7
50
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies
Seminars in Arthritis and Rheumatism
2021
6
site/software ©
exaly
; All materials licenced under
CC by-SA
.